about
Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingAttenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division/mitophagy inhibitorA novel compound NSC745885 exerts an anti-tumor effect on tongue cancer SAS cells in vitro and in vivoProtective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolismPotent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirusEvaluation of Short-Term Use of N-Acetylcysteine as a Strategy for Prevention of Anthracycline-Induced Cardiomyopathy: EPOCH Trial - A Prospective Randomized Study.SUMO modification of DNA topoisomerase II: trying to get a CENse of it allTrastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise.Comparison of doxorubicin cardiotoxicity in pediatric sarcoma patients when given with dexrazoxane versus as continuous infusion.Fetal outcome after prenatal exposure to chemotherapy and mechanisms of teratogenicity compared to alcohol and smoking.Albumin nanostructures as advanced drug delivery systems.Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin.Protective role of Osthole on myocardial cell apoptosis induced by doxorubicin in rats.Strain echocardiography in early detection of Doxorubicin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia.Effects of Agaricus blazei Murill extract on sensitivity to chemotherapeutic agents in HeLa cells and its resistant sublines.Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model.Differential toxicity of anthracyclines on cultured endothelial cells.Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart.Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity.Influence of the formulation on the maximum tolerated doses of brain targeted nanoparticles of gallic acid by oral administration in Wistar rats.Competition between self-inclusion and drug binding explains the pH dependence of the cyclodextrin drug carrier - molecular modelling and electrochemistry studies.
P2860
Q28389739-14C79258-B913-46D6-B222-4AEEF922E498Q28534483-82E2BF75-FEEE-4148-9C57-2EC0370FC238Q28541985-A4C5323D-AA0F-45CE-AB21-0D30D64EEC4BQ28606782-1F944938-F4AC-4673-AF46-8CFAA62E3874Q35689364-5E6BBC23-90FA-4810-BB3E-8F8ECC1FC678Q36774710-FB6733F7-956B-4311-B8CE-30ACDF85417AQ37207512-DB428D78-A5EE-4D80-9EFC-1AEB931F888EQ37378906-FA1099F3-7F1F-487A-B4AF-1F55B270ABDEQ37783289-15F1AEFB-E367-447D-89D2-F145306829D5Q38266407-DE9930C6-B5E5-4F3E-BF31-B303BC6B34EAQ38842596-B14F4870-12C3-4DD4-AF45-799FFD52B56CQ40943399-6E8EB538-20D6-4B1F-B4D4-FD1DCF4D3598Q41861138-F53C7499-7A50-4B85-8BC0-389EAE3B2176Q42019686-F0415A5C-0DBF-4FF2-9F6B-E387873E1D6AQ42720373-8197F024-730E-45C2-9280-15143C9197D3Q42947243-9E4EE516-F2D2-42A4-AB05-A550C6A1315FQ46171847-629CB683-965C-4EF6-A4D2-B39D45A2B3F0Q46374470-8AE5755B-EA4C-4380-96A4-953F684A9D75Q46450246-034C2994-6255-41C7-B644-39E569699FBAQ46740080-A7C0A0E5-DDC4-466F-9C02-F9B641FD5DB9Q48870977-E9732EB2-4667-40A9-B3D9-16BCD7FEFB46Q52889033-89549F51-A289-4DD3-8646-441989F7086E
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cardiac toxicity of antineoplastic anthracyclines.
@ast
Cardiac toxicity of antineoplastic anthracyclines.
@en
type
label
Cardiac toxicity of antineoplastic anthracyclines.
@ast
Cardiac toxicity of antineoplastic anthracyclines.
@en
prefLabel
Cardiac toxicity of antineoplastic anthracyclines.
@ast
Cardiac toxicity of antineoplastic anthracyclines.
@en
P356
P1476
Cardiac toxicity of antineoplastic anthracyclines
@en
P2093
Riccardo Zucchi
Romano Danesi
P304
P356
10.2174/1568011033353434
P577
2003-03-01T00:00:00Z